Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
Public ClinicalTrials.gov record NCT02576457. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Subjects With Severe Sepsis
Study identification
- NCT ID
- NCT02576457
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Interventions
- BMS-936559 Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1, 2015
- Primary completion
- Mar 14, 2017
- Completion
- Mar 14, 2017
- Last update posted
- Sep 14, 2017
2015 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Uc Davis Medical Center | Sacramento | California | 95817 | — |
| Local Institution | Denver | Colorado | 80204 | — |
| University Of Florida | Gainesville | Florida | 32610 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Osf Saint Francis Medical Center | Peoria | Illinois | 61637 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | — |
| University of Michigan, Division of Acute Care Surgery | Ann Arbor | Michigan | 48109-5033 | — |
| Washington University School Of Medicine | St Louis | Missouri | 63110 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| St. Vincent'S Medical Center | Toledo | Ohio | 43603 | — |
| UPMC | Pittsburgh | Pennsylvania | 15261-2500 | — |
| Local Institution | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02576457, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02576457 live on ClinicalTrials.gov.